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Abstract
Cultured Drosophila melanogaster S2 and S2R + cell lines have become important tools for
uncovering fundamental aspects of cell biology as well as for gene discovery. Despite their utility,
these cell lines are nonmotile and cannot build polarized structures or cell-cell contacts. Here we
outline a previously isolated, but uncharacterized, Drosophila cell line named Dm-D17-c3 (or
D17). These cells spread and migrate in culture, form cell-cell junctions and are susceptible to
RNA interference (RNAi). Using this protocol, we describe how investigators, upon receiving
cells from the Bloomington stock center, can culture cells and prepare the necessary reagents to
plate and image migrating D17 cells; they can then be used to examine intracellular dynamics or
observe loss-of-function RNAi phenotypes using an in vitroscratch or wound healing assay. From
first thawing frozen ampules of D17 cells, investigators can expect to begin assaying RNAi
phenotypes in D17 cells within roughly 2–3 weeks.
INTRODUCTION
Cultured Drosophila melanogaster cells have become powerful genetic tools for the study of
numerous cell biological processes. Established lines such as S2 and S2R + offer high-
resolution cytology, simple culture conditions, a fairly homogeneous morphology when
seeded on the lectin concanavalin A, and, most notably, a potent susceptibility to RNAi that
can be applied on a genomic level1–5. These benefits are additionally advantageous because
of the succinct nature of the fly genome6 (~14,000 genes) and the potential to easily move
cell culture observations into a model organism7. The end result has been a cell culture
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system that has been applied to disciplines as diverse as developmental biology8–10,
microbiology11 and high-throughput functional genomics12,13.
Although lines such as S2 and S2R + have advanced our understanding of the basic
mechanisms underlying cell morphology and cytoskeletal organization, their use is
somewhat limited in this regard because of their lack of true cell locomotion. Moreover,
these cell lines usually exist in culture as single, rounded cells that lack characteristics such
as cell-cell junctions, which are necessary structures for organismal development.
The Drosophila Genomics Resource Center (DGRC, http://dgrc.cgb.indiana.edu/) in
Bloomington, Indiana, is a repository for dozens of Drosophila cell lines derived from
various fly tissues at different developmental stages. Many of these cell lines have remained
uncharacterized with respect to their ability to respond to RNAi or their real-time dynamics
in culture.
One such line, Dm-D17-c3 (hereafter referred to as D17), was isolated in addition to roughly
two dozen other cell lines in the lab of the late Tadashi Miyake at the Mitsubishi-Kasei
Institute of Life Sciences in Tokyo. Although only half of these lines were ever published14,
the entire collection of cell lines isolated from third instar larvae is currently available at the
DGRC (http://dgrc.cgb.indiana.edu/cells/store/catalog.html?category=2). The D17 and their
sibling lines were cultured from dissected imaginal discs, pools of multipotent cells in the
developing Drosophila larvae responsible for creating the vast array of adult tissue needed
during metamorphosis.
Characteristics of D17
When observing D17 cells in culture, the cells show a more heterogeneous set of
morphologies than S2 cells, but usually spread and form islands of epithelial-like colonies or
migrate nondirectionally as single cells. In confluent culture, the cells often form a complete
monolayer, but are not classically contact inhibited, resulting in foci of cells that build up
above the surface of the cell monolayer. Time-lapse video microscopy of D17 cells revealed
a robust motility of approximately 25–30 μm h−1 (Fig. 1), similar to the initial speeds of
Drosophila hemocytes in vivo as they migrate along the ventral midline15 (~24 μm h−1).
Additionally, when migrating, these cells adopt a morphology reminiscent of mammalian
cells migrating in culture; producing a polarized, triangular organization with a large fan-
like lamella at the leading edge and trailing retraction fibers in the rear of the cell (Fig. 2 and
Supplementary Video 1).
Although the D17 cells were originally believed to be epithelial cells due to the nature of the
tissue they were derived from14, the cells have properties reminiscent of Drosophila
hemocytes, which are migratory Drosophila immune cells. This is evident from their similar
morphological properties during migration16 as well as the propensity of D17 for phagocytic
clearance. Indeed, we often observe D17 cells in culture that exhibit a chemotactic attraction
to the debris of their apoptosed neighbors and even undergo whole-cell engulfment (J.D.C.
and S.L.R., unpublished observations). D17 cells also mimic hemocytes in their ability to
secrete extracellular matrix (ECM), which they require for migration (see Box 1). In
addition to this observational evidence for the D17's possible cell lineage, thanks to recent
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genomic information available from the modENCODE project17 (http://
www.modencode.org), we can make inferences about the differentiated state of the D17 cell
line based on their transcriptional profile. Using these online tools we have found that,
similarly to S2 and S2R + cells, D17 cells express elevated message levels of the hemocyte-
specific transcription factor Serpent18 as well as other hemocyte-specific genes, suggesting
that these two cell lines may have comparable expression profiles. Recent work from the
modENCODE project has further characterized the transcriptional profile of 25 established
Drosophila cell lines, including the D17 cell line19. Expression profile clustering
demonstrated that D17 cells share broad expression similarities to embryonic S2R + cells.
However, on the basis of the expression of the homeotic transcription factor, teashirt20, in
D17 cells, the authors conclude that D17 cells are indeed imaginal haltere disc cells19. This
conclusion is somewhat confounded by the fact that embryonic S2 and S2R + cells also
express relatively high levels of teashirt based on modENCODE expression data and it
seems that this fact alone does not explicitly reveal the identity of the D17 cell line. Further
work will be necessary to establish the identity of the D17 cell line based on gene
expression, cell biological observations and biochemical analysis between various
Drosophila cell lines. Hopefully, continued use of the D17 cell line will further open up
intriguing questions about the mechanisms of cell identity, cell morphology and cell
motility.
Advantages and key applications of D17
The key component that makes Drosophila cells an advantageous system is their potent
susceptibility to RNAi and the relative simplicity of producing and treating cells with
double-stranded RNA (dsRNA). Generally, this procedure involves creating dsRNA that is
transcribed from a target DNA template with flanking T7 RNA polymerase start sites.
Addition of the produced dsRNA to cell growth medium is sufficient to induce cellular
uptake and gene depletion3 without the use of lipid-based transfections or virus infection.
This methodology has been greatly enhanced by commercial and academic resources that
provide online tools for designing dsRNA primers (Harvard Drosophila RNAi Screening
Center (DRSC), http://www.flyrnai.org), obtaining cDNA templates (Open Biosystems,
http://www.openbiosystems.com) and procuring genome-wide as well as custom
sublibraries (Harvard DRSC) of RNAi targets.
The utility of the D17 cell line should augment the studies of many in the cell biology and
Drosophila communities who wish to study target genes and pathways in the context of
biological processes such as cell migration and cell-cell interactions (Fig. 3). In addition,
many of the protocols already established for S2 cell culture21 can easily be adapted for D17
cell culture. The D17 cell line represents an untapped resource to answer existing questions
in various fields as well as provide a model to ask new questions about the genetic basis of
cell migration, chemotaxis and cell differentiation.
Overview of the procedure
We outline how to thaw frozen ampules from the DGRC and establish cultures that can be
passaged; prepare D17 growth medium; and isolate a crude ECM preparation from
conditioned media that allows users to plate D17 cells on glass surfaces. We will also
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outline how to experimentally assay D17 cells by transient transfection, dsRNA treatment,
and examine migration through a classical wound healing assay that can be used to analyze
RNAi phenotypes. Using the protocols outlined here, we have previously been able to
demonstrate the negative regulation of D17 migration by the microtubule-severing enzyme,
katanin22.
Experimental design
RNAi—D17 cells can be treated in much the same way as common S2 and S2R + lines
(Steps 10–14). For any RNAi experiment, it is important that users include important RNAi
controls to ensure that RNAi phenotypes are penetrant and effectively affect migration. We
recommend using the small GTPase Rho as a positive control for penetrant RNAi
phenotypes in S2 cells and D17 cells, as its knockdown can be assayed by western blotting
(Fig. 1e) and produces an easily visible multinucleate phenotype (Fig. 1d)21,23.
As a positive control for RNAi migration phenotypes, we suggest using the Drosophila
Arp2/3 activator SCAR. SCAR exists as a single isoform in Drosophila and markedly
inhibits D17 migration (Fig. 1c). RNAi against the small GTPase Rac can also be used to
inhibit D17 migration, but investigators should note the compensatory effects of the two
Drosophila Rac isoforms and related GTPase Mtl24,25. Control-treated cells can be treated
with dsRNA made against the Bluescript plasmid21.
The depletion of target proteins can vary between cell lines depending on the differential
stability or expression level of the target polypeptide as well as the kinetics of protein
dilution through sequential cell divisions, making a direct comparison of RNAi efficacy
between S2 cells and D17 cells tenuous at best. Immunoblots of tubulin and Rho from
equally loaded lysates reveal that S2 and D17 cells express different levels of both proteins.
Seven-day treatment of dsRNA using the protocol outlined here results in a similar degree of
knockdown between cell lines (Fig. 1e). We suspect that the kinetics of protein depletion
may be slightly slower in D17 cells as a result of their longer doubling time of 48–72 h
versus a 24-h doubling time in S2 cells (J.D.C. and S.L.R., unpublished observations). In our
hands, potent depletion (greater than 80% knockdown) in D17 cells can usually be obtained
within 7–9 d. We recommend that investigators empirically optimize the length of dsRNA
treatment in D17 cells for each RNAi target to achieve the optimal knockdown.
Isolation of the ECM—The methodology described in Box 1 is based on the early
purification steps for isolating Drosophila ECM components outlined by John Fessler26 of
the University of California, Los Angeles. We have not yet identified the specific ECM
components or factors that support D17 growth. Despite our attempts, commercial
mammalian ECM components do not seem to replicate D17 ECM, and D17 ECM is not
competent to convey cell spreading or motility to nonmotile S2 or S2R + cells. D17 ECM is
essential for culturing D17 cells on glass surfaces for wound healing assays, single cell
motility or fluorescent visualization. Although the above-mentioned assays can be
performed in tissue culture–treated plastic vessels, the use of glass surfaces allows greater
resolution and decreased chromatic aberrations. One alternative is using a tissue culture–
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treated optical polystyrene that does not require ECM coating and can be used for oil
immersion microscopy.
Because the concentration of ECM components can vary from batch to batch, it is important
that investigators test newly made ECM to ensure consistency across many experiments. To
do this, investigators should plate and image D17 cells at a range of ECM concentrations
(diluted in PBS, see Step 15, generally ranging from 1:10 to 1:300). Analyzing the velocity
and other parameters of migration (see Step 23) for each concentration should allow
investigators to find an ECM concentration that either replicates results from a previous
ECM batch or has the desired parameters of migration for a given experimental approach.
Transient transfection—D17 transfection will allow the user to image the dynamics and
localization of exogenous transgenes through high-resolution immunofluorescence, or in
real time using bioluminescent tags such as enhanced green fluorescent protein. D17 cells
are amenable to transfection with most of the expression constructs currently used for S2
cells. One caveat is that D17 cells seem to be somewhat insensitive to the commonly used
metallothionein promoter constructs (referred to as pMT vectors). These reagents can be
used, but require substantially higher doses of copper sulfate to induce gene expression
(between 500 μM and 5 mM concentrations). On the basis of our experience, constitutive
promoters such as the actin promoter or the OpIE2 promoter give medium to high levels of
expression and can be used when an endogenous promoter is unavailable. It is important that
researchers use the proper controls to both ensure the expression of their desired transgene
and to account for deleterious effects on D17 cell viability and cell migration. Expressing
the empty vector backbone of a given transgene that only expresses an affinity or
bioluminescent tag in D17 cells can both troubleshoot problems with the transfection
protocol and control for the effects of toxic gene expression with a given assay. Users can
also test transgenes by transfection in S2 cells or other nonmotile Drosophila cell lines to
determine the effects of their transgene on cell morphology. Using this protocol we normally
achieve 10–40% transfection efficiency in D17 cells after 48 h. The transfection protocol
outlined here differs from protocols for transecting S2 cells, by which we can commonly
achieve 20–70% transfection efficiency, but both cell types seem to respond poorly to the
transfection protocol of the other cell type.
Migration assays—The ability to assay cell migration is the key strength of designing
experiments using the D17 cell line. Here we outline a classical wound healing assay that
has been previously used to measure the migratory capability of mammalian cells27. One of
the key advantages of this kind of assay is that it can easily be scaled from the examination
of single conditions to high-throughput assays of many dsRNA treatments or conditions28.
We previously used this method to initially determine that depletion of the micro-tubule-
severing protein, katanin, leads to an increase in the rate of wound closure22. We then went
on to examine the migration parameters of single cells migrating at subconfluent densities.
This twofold approach allowed us to determine an initial phenotype before further defining
the exact mechanism of this migratory gain of function22. In addition, investigators can
often combine the two techniques (as described in Step 22) to measure both wound closure
as well as the migratory properties of single cells moving into the wound.
Currie and Rogers Page 5






















When imaging D17 cells as single cells or within the context of a scratch wound assay, it is
important that investigators consider: (i) the resolution of observation, (ii) the temporal
resolution of time series acquisition and (iii) the maintenance of consistency between
conditions.
The magnification used for acquiring images of D17 migration should encompass the entire
wound when using a scratch wound assay. When tracking single cells, the resolution for
image acquisition should also be adequate to provide the necessary contrast and resolution to
faithfully track cells as well as determine differences in morphology. We recommend using
between ×10 and ×20 magnification for the scratch wound assay, and increasing
magnification to between ×20 and ×40 when imaging and tracking single D17 cells.
Users should be aware of the spatial resolution they are using to follow D17 migration.
During a scratch wound assay, users should empirically determine, on the basis of the size of
their scratch, a time frame in which it would be feasible to detect both loss- and gain-of-
function migration phenotypes. This often means setting a final time point where control-
treated cells migrate into the wound but do not completely fill the wound area.
When creating a time-lapse series of wound healing or of sub-confluent, single D17 cells,
users should ensure that the rate of image acquisition is adequate to capture all cell
movements. Lengthy intervals might lose small movements of cells and potentially skew
measurements of directionality and velocity. This should be balanced by limiting the cell's
exposure to heat and evaporation caused by light illumination. Typically, intervals of 3–7
min should be an adequate rate of acquisition to alleviate these effects.
Finally, users should attempt to maintain consistent assay conditions across various
experimental conditions. This includes the number of cells treated and plated for each
condition, although this can difficult to achieve when treatments affect cell viability.
Performing a wound healing assay with a pipette tip can also cause inconsistencies between
conditions. Users should attempt to create the most uniform scratches possible between
wells by maintaining a constant angle and pressure on the pipette tip while wounding cell
monolayers. Custom and commercial apparatus can also be used to aid in wounding
multiwell plates of D17 cells28,29.
At present, one of the primary limitations of using the D17 cell line is the lack of directional
migration assays toward chemotatic, haptotatic or durotatic cues. Analysis of D17 migration
using a scratch wound assay or imaging single cells migrating in culture is currently
restricted to the nondirectional migration of cells on the basis of our lack of known guidance
cues. Because the migration of D17 cells is random, it can also lead to heterogeneity in the
total number of cells in a population that are migrating as well as the persistence of
migration in a single direction and the duration of migration. Investigators should be aware
of this limitation and repeat experiments at least three times, sampling an adequate number
of cells to truly determine the effect of dsRNA or other treatment on a population of cells.
Understanding the cues that govern D17 motility will be an important advance to harness
these guidance cues to spatially and temporally direct D17 migration.
Currie and Rogers Page 6
























• ML-DmD17-c3 cell stocks are available from the DGRC (http://dgrc.cgb.indiana.edu/)
• Schneider's insect medium (Invitrogen, cat. no. 11720-034)
• Antibiotic/antimycotic (Invitrogen, cat. no. 15240-096)
• FBS (Invitrogen, cat. no. 10099-141)
• Human insulin (Invitrogen, cat. no. 12585-014) ● CRITICAL Many vendors sell FBS
that is already heat-inactivated, usually at temperatures exceeding 65 °C. This heat-
inactivated serum is not suitable for D17 cell culture, as it does not support long-term cell
passage, presumably because of the inactivation of important trophic factors. Non–heat-
inactivated serum can be purchased and heat-inactivated by submerging the thawed serum in
a 55 °C water bath for 1 h with occasional inversions to mix the serum.
• Cell dissociation buffer, PBS based (Invitrogen, cat. no. 13151-014)
• D17 growth medium (see REAGENT SETUP) ● CRITICAL D17 growth medium should
be made in advance of receiving frozen ampules from the Bloomington stock center.
• Sulfuric acid (Fisher Scientific, cat. no. SA212-1) ● CAUTION Caustic reagent.
• Hydrogen peroxide (Fisher Scientific, cat. no. H325-100) ● CAUTION Irritant.
• Sterile PBS (Invitrogen, cat. no. 10010-023)
• Saturated ammonium sulfate solution (Sigma-Aldrich, cat. no. A6387; see REAGENT
SETUP) ● CAUTION Irritant. Users should wear gloves when handling ammonium
sulfate.
• Conditioned D17 growth medium (see Box 1)
• Fugene HD transfection reagent (Roche, cat. no. 04709705001)
• Sterile water
• Suitable transfection vectors, e.g., metallothionein promotor (pMT vectors; Invitrogen, cat.
no. V4120-20), OpIE2 promoter pIZ vectors (Invitrogen, cat. no. V800001) or actin
promoter pAc5.1 vectors (Invitrogen, cat. no. V4110-20). Vector backbones can be modified
or purchased to accommodate bioluminescent probes and other user-specific transgenes.
• D17 freezing medium (see REAGENT SETUP)
• DMSO
• Distilled, deionized water
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• dsRNA (these are user-defined and created using standard methods21)
EQUIPMENT
• UV transilluminator (such as Fisher Scientific, cat. no. PBDLT88AQ) or other power
source such as a plasma treater that can bombard treated cover slips with at least 8,000 μw
cm −2 ● CAUTION Always use appropriate eye and skin apparatus and necessary shielding
when using UV light.
• Polystyrene Petri dishes (35 mm × 10 mm; Becton Dickinson, cat. no. 351008)
• Glass-bottom multiwell plate (Greiner, cat. no. 662892)
• Optical grade polystyrene/polymer base multiwell plate (Nunc, cat. no. 165305)
• Glass cover slips, no. 1.5, 22 mm2 (Corning, cat. no. 2940-225)
• Cover slip rack, porcelain (Coors, through Thomas Scientific, cat. no. 8542E40)
• Swinging-bucket tabletop centrifuge
• Tissue culture flask vessels (25 cm2, T25; Becton Dickinson, cat. no. 353082)
• Tissue culture flask vessels (75 cm2, T75; Becton Dickinson, cat. no. 353135)
• Sterile, laminar flow hood
• Sterile bottle-top filter flask (500 ml; Corning, cat. no. 431117)
• Cell scraper (25 cm; Becton Dickinson, cat. no. 353086)
• Dialysis tubing (Pierce, cat. no. 68035)
• Dialysis clips (Pierce, cat. no. 68011)
• Inverted microscope with charge-coupled device camera
• Microscope image acquisition software, e.g., MetaMorph (Molecular Devices) or NIS
Elements (Nikon)
• ImageJ software (http://rsbweb.nih.gov/ij/) and Manual Tracking plugin (Fabrice
Cordelières, http://rsbweb.nih.gov/ij/plugins/track/track.html)
EQUIPMENT SETUP
Cover slip preparation—Before ECM-treating glass cover slips, cover slips should be
cleaned by immersion in a strong acid for at least 1 h. Before treatment, load untreated cover
slips into porcelain racks. To prepare the acid solution, add two parts sulfuric acid to one
part hydrogen peroxide. Typically, this volume is 200 ml of sulfuric acid added to 100 ml of
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hydrogen peroxide within a 1 liter glass beaker. Carefully lower the porcelain rack(s) into
the acid solution and ensure that the cover slips are fully immersed. After 1-h acid treatment,
cover slips should be rinsed continuously with sterile running water for 15 min and dried.
Once dry, place in 35-mm dishes either individually or together to prevent dust
accumulation on their surface.
REAGENT SETUP
D17 growth medium—Prepare growth medium (cell culture medium) within a sterile,
laminar flow hood by combining 5 ml of antibiotic/antimycotic (100× stock concentration),
50 ml of heat-inactivated FBS (10% total medium volume), 1.25 ml of human insulin (4 mg
ml −1 stock concentration to final 10 μg ml −1 final concentration) and 445 ml of Schneider's
medium to a final volume of 500 ml. This solution should then be sterile filtered using a 2-
μm filter flask to exclude any precipitated serum or contaminates. Store at 4 °C and warm to
room temperature (~25 °C) before use. D17 growth medium is stable for 1–3 months,
although serum crystals will form over time. These crystals should remain on the bottle
bottom and do not seem to affect D17 culture.
D17 freezing medium—D17 freezing medium should be freshly made before each use by
mixing 4 ml of conditioned D17 growth medium, 4 ml of fresh D17 growth medium and 1
ml of sterile DMSO.
Saturated ammonium sulfate solution—Prepare a saturated ammonium sulfate
solution by adding ~750 g of ammonium sulfate to 1 liter of distilled and deionized water.
Heat the solution until the ammonium sulfate is totally dissolved and then cool to room
temperature (25 °C). Upon cooling, crystals should form, indicating the solution is indeed
saturated. The saturated ammonium sulfate can be stored and used at room temperature and
has an indefinite shelf life.
PROCEDURE
Thawing D17 cells ● TIMING 1.5–2.5 h
1 In a sterile laminar flow hood, add 7 ml of D17 growth medium to a T25 tissue culture
flask; this should be carried out before thawing the cells.
● CRITICAL STEP Because the delivery conditions of dry ice are suboptimal for the
storage of frozen cells, it is important that the ampule of cells be plated as soon as it arrives.
2 Remove the vial of cells from the dry ice delivery container and immerse the bottom of the
ampule in a 37 °C water bath, shaking often to thaw the ampule as quickly as possibly to
room temperature.
● CRITICAL STEP All attempts should be made to keep the cryovial lid from coming into
contact with the water bath water. This will prevent contamination of the D17 cells.
3 Once the ampule contents are liquid, remove from the water bath and sterilize the ampule
by wiping the outside with a 70% (vol/vol) ethanol solution.
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4 In the laminar flow hood, add the contents of the ampule to the 7 ml of D17 growth
medium in the T25 culture flask prepared in Step 1.
5 Leave the cells for 1–2 h at room temperature (25 °C) to attach and spread on the bottom
of the culture flask.
6 Remove the medium and replace it with a fresh 7 ml of growth medium to remove any
DMSO that was present in the frozen cell solution. Grow D17 cultures in a sterile incubator
or on a shelf at 25 °C. Flasks do not require gas exchange vents or special atmospheric
considerations.
Passaging D17 cultures ● TIMING 20 – 60 min
7 Remove the D17 growth medium from the culture flask and store this conditioned medium
at 4 °C for ECM production (see Box 1).
8 Split D17 cells using either cell dissociation buffer (option A) or using a cell scraper
(option B).
(A) Passaging using dissociation buffer
(i) Wash the cells in the culture vessel by gently pipetting 2 ml of cell dissociation buffer
onto the cells, briefly tilting the vessel to allow the buffer to wash over the cells, and then
removing the buffer with a pipette from the tilted culture vessel.
(ii) Add another 2 ml of cell dissociation buffer, or enough volume to cover the bottom of
the flask. Incubate the cells for 25–30 min at room temperature outside the laminar flow
hood. Under magnification, the cells should be seen to round up and lose cell-cell
adhesion. ? TROUBLESHOOTING
(iii) Gently remove the cell dissociation buffer with a pipette and add 5 ml of fresh D17
growth medium. Vigorously pipette the medium up and down several times to detach the
cells from the bottom of the culture flask.
(B) Passaging using a cell scraper
(i) Add 6 ml of fresh D17 growth medium to the flask. Insert the cell scraper into the flask
and move the blade across the flask bottom, trying to remove a maximum amount of cells
with the fewest blade strokes.
9 Seed the cell suspension into new culture vessels at concentrations of 1 to 2 × 106 cells per
ml or roughly 40–60% confluency in either a T25 or T75 flask. The D17 cells should reach
100% confluency after 3–7 d depending on the concentration of cells seeded. Within the
culture flask, the cells should reach a monolayer with small foci of additional cell growth
above the monolayer. In cases where the cells are grown from sparse conditions, the user
may find large colonies of cells that form islands of monolayers with exaggerated foci of
cells on top. This is also adequate to passage to new vessels, as the cells contained within the
foci should be competent to repopulate a new vessel. Aliquots of D17 cells can be frozen in
D17 freezing medium using previously published protocols for S2 cells21.
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● CRITICAL STEP The growth rate and survival of D17 cells is very sensitive to plating
density. The most common error when culturing D17 is to plate them at low densities, which
can result in extremely slow growth or cell death. An optimal density of 40–60% is essential
for healthy cells and confluent passaging between 3 and 6 d.
● CRITICAL STEP The user should keep track of passage iterations, as D17 cells will
reach a terminal state after 25–30 passages, at which point they may respond poorly to
RNAi or transfection and may have slow growth or abnormal morphology. ?
TROUBLESHOOTING
RNAi treatment ● TIMING 7–9 d
10 Plate cells in tissue culture–treated multiwell culture vessel at subconfluent density (40–
60% or 4,000–5,000 cells mm −1). We recommend performing RNAi in tissue culture-
treated vessels and then transferring cells to cover slips or glass vessels, when possible.
11 Allow the cells to adhere to the vessel bottom for 1 h at room temperature (25 °C). If
desired, cells can be transfected (see Box 2) within 30 min after plating and at anytime
during RNAi treatment.
12 Remove medium and replace with culture medium containing ~10 μg ml −1 dsRNA.
Treated cells should be incubated as normally passaged cells at room temperature (25 °C).
13 Repeat dsRNA treatment (Step 11) every 2 d for 7–9 d of treatment.
14 At 6–9 d of dsRNA treatment, harvest cell lysates for western blot analysis or transfer to
ECM-coated vessels (Steps 15–18) to assay for loss-of-function phenotypes; for example,
migration phenotypes can be assayed as described in Steps 19–22 below. The user should
empirically determine the optimal length of treatment for each dsRNA construct and gene
product. ? TROUBLESHOOTING
Plating D17 cells on ECM-coated surfaces ● TIMING 1 h
15 Use a stock solution of D17 cell ECM (see Box 1) to dilute the ECM solution in sterile
PBS to the desired concentration. The exact concentration of ECM will need to be
determined empirically by the user on the basis of the optimal assay conditions and the yield
of ECM purified per batch (see EXPERIMENTAL DESIGN). As a general starting point,
dilutions of ECM to PBS ranging from 1:50 to 1:200 seem to support robust attachment and
migration in our hands. ? TROUBLESHOOTING
16 Apply enough of the ECM/PBS solution to cover the surface of the cover slip or glass-
bottom plate intended for culture.
17 Cross-link the ECM solution to the glass surface by plasma treatment for several minutes
or high-energy UV treatment for 45 min. For many users, placing the dish or cover slip onto
the surface of a UV transilluminatior used to visualize ethidium bromide–stained agarose
gels is sufficient, provided it can produce enough energy (~8,000 μw cm −2) to cross-link the
ECM to the glass surface.
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● CRITICAL STEP D17 cells should be plated within several hours of ECM cross-
linking. Plasma or UV treatment is a temporary cross-linking procedure, which can affect
the efficiency of D17 adherence and motility for some applications. ?
TROUBLESHOOTING
18 After cross-linking, remove the ECM/PBS solution. Plate the cells at the desired density
to produce an adherent monolayer or single cells. D17 cells should adhere and spread on the
cross-linked glass surface within 1 h. Cells are viable on these cross-linked surfaces for
several days and can proliferate to form confluent monolayers if plated in subconfluent
number. Generally, for subconfluent plating, cell densities of 4,000–5,000 cells per mm of
surface are sufficient, or densities of 7,000–8,000 cells per mm when cell monolayers are
desired.
Wound migration assay ● TIMING 18–24 h
19 Seed cells at monolayer densities on either tissue culture–treated vessels or ECM-coated
glass surfaces at room temperature (25 °C). Cells can be allowed to settle anywhere from 2
to 24 h before wounding cell monolayers. Additionally, if too few cells are initially seeded,
users can apply additional cells to increase the confluency of D17 cells to monolayer
density.
20 Once monolayers are obtained, use a 200-μl pipette tip or other pointed implement to
scratch though the monolayer, creating a wound. Wounds should be at least 200 μm in size
without visible obstructions of cell debris or substrate etching.
21 Once wounded, pipette off the growth medium and wash the wells with fresh medium to
remove debris.
22 Mount the vessel on an inverted light microscope with phase-contrast or differential
interference contrast filters and begin imaging. D17 wounded monolayers can be imaged
over the course of 18–24 h using either discrete time points (option A) or a time-lapse series
(option B).
(A) Imaging D17 wounded monolayers using discrete time points
(i) Keep the vessel stationary on the inverted microscope throughout the migration assay and
acquire images of the wound at regular intervals; alternatively, acquire a set of images
representing the beginning and end of the migration assay.
(ii) After acquiring all time point images, use ImageJ software to outline the scratch area and
measure the area of the wound at each time point. Compare the total area between the initial
time point and later time points to obtain the percentage of wound closure over a given time.
(B) Imaging D17 wounded monolayers using a time-lapse series
(i) Keep the vessel stationary on the inverted microscope throughout the course of the assay,
and acquire images at regular intervals of between 3 and 7 min (see EXPERIMENTAL
DESIGN).
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(ii) Use ImageJ software to assemble time-lapse intervals into a multi-image tiff file.
(iii) Apply the Manual Tracking plug-in to the multi-image tiff files to track individual cells
as they migrate into the wounded area. Parameters such as instantaneous and mean velocity,
distance and directionality can be obtained using this plug-in. Analysis of D17 single-cell
motility at subconfluent densities can also be performed using Steps 22B(i–iii).
? TROUBLESHOOTING
Troubleshooting advice can be found in Table 1.
● TIMING
EQUIPMENT SETUP, Cover slip preparation: ~1.5 h
REAGENT SETUP, D17 growth medium: ~15 min once all ingredients are thawed
REAGENT SETUP, Saturated ammonium sulfate: ~30 min
Steps 1–6, Thawing D17 cells: 1.5–2.5 h
Steps 7–9, Passaging cells: 20–60 min
Step 8(A), Passaging using cell dissociation buffer: 25–60 min
Step 8(B), Passaging cell scraper: 20 min
Steps 10–12, RNAi plating and initial treatment: 1.5 h
Step 13, Subsequent dsRNA treatment: 30 min
Step 14, Full dsRNA treatment: 7–9 d Steps 15–18, Plating D17 cells on ECM surfaces: 1 h
Steps 19–22, Wound healing assay, 18–24 h; can be performed concurrently with the end of
dsRNA treatment
Box 1, Preparing D17 ECM: 18–24 h
Box 2, D17 transient transfection, 30 min; can be performed concurrently with dsRNA
treatment, wound healing treatment or both
ANTICIPATED RESULTS
Using either a wound healing assay (Fig. 1a and Supplementary Video 2) or by imaging
single cells (Fig. 2) over various time periods, the investigator can acquire time-lapse data
sets from which they may derive various parameters of cell migration, including distance,
velocity (Fig. 1b) and directional persistence. In a wound healing assay, an investigator can
expect control-treated cells to migrate from both sides, not necessarily as a single-cell sheet,
to fill in approximately 150–250 μm of the wound area over 18–24 h.
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By optimizing the duration of dsRNA treatment to obtain greater than 85% knockdown by
western blot analysis, the user should expect a highly penetrant RNAi migration phenotype.
Combining transfection of D17 cells with a wound healing assay or single-cell migration
assay will also allow the user to determine the effects of overexpression on cell migration.
Investigators can also take advantage of dsRNA against the 5[.radicalex] or 3[.radicalex]
untranslated region of an endogenous gene, allowing them to express exogenous cDNA
transgenes to examine the sufficiency of a particular gene to rescue RNAi migration
phenotypes. In these cases, the lower transfection efficiency of 10–40% expressing cells can
be advantageous, as the user can use untransfected cells within the same condition as
controls.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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BOX 1 PREPARING D17 EXTRACELLULAR MATRIX ● TIMING 18–24 H
1. Collect conditioned medium from confluent flasks of adherent D17 cells and store at 4
°C. This can be collected every 3 d from 100% confluent flasks or every 6 d from
subconfluent flasks. The most straightforward approach is to save the medium that cells
have been cultured in when passaging cells to new culture vessels.
2. Once a sufficient amount has been collected (at least 100 ml), spin the medium at 200g
for 10 min to remove any cells or large precipitants.
● CRITICAL STEP Because there is some variability between lots of prepared ECM, it
is important in an effort to maintain consistency that a large enough batch of conditioned
medium is processed to accommodate the user's aims. To this end, we would recommend
processing between 200 and 400 ml of conditioned medium at any one time, which will
produce enough ECM to last the user for more than 100 experiments, depending on the
final concentration at which it is used.
3. Pour the cell-free medium into a glass beaker and stir slowly on a stir plate.
4. Add ~40% volume of saturated ammonium sulfate dropwise to the slowly stirring
medium (i.e., 40 ml ammonium sulfate added to 100 ml conditioned medium). The key to
success at this step is to continue adding ammonium sulfate until the medium is cloudy
and opaque (which indicates the precipitation of large proteins out of solution) rather
than adding a precise volume.
5. Pour the precipitated medium solution into 50-ml conical tubes and spin at speeds in
excess of 3,000g for 30 min to 1 h at 4 °C. After centrifugation, the precipitated proteins
should be pelleted and the supernatant should again be clear.
6. Discard the supernatant and resuspend the pellet in 1/100th of the original medium
volume (i.e., for 100 ml of conditioned medium, resuspend the pellet in 1 ml) in cold,
sterile PBS.
7. Pipette the resuspend pellet into a dialysis bag and dialyze in 1 liter of PBS at 4 °C,
changing the PBS out 2–3 times over the course of 16–24 h to remove the ammonium
sulfate from the ECM solution.
● PAUSE POINT The resuspended ECM pellet can be left to dialyze in fresh PBS
overnight at 4 °C.
8. Aliquot the dialyzed ECM into 1.7-ml microcentrifuge tubes and spin in a tabletop
centrifuge at 4 °C at speeds in excess of 16,000g for 10 min and transferring the
supernatant to another microcentrifuge tube to remove any remaining precipitate.
9. The ECM is now ready for use (see Steps 15–18 of the main PROCEDURE). Test
each new batch for efficacy to match the ideal assay conditions (see EXPERIMENTAL
DESIGN).
● PAUSE POINT ECM can be stored short-term (1–2 months) at 4 °C or long-term by
flash-freezing it in liquid nitrogen and storing at − 80 °C.
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BOX 2 TRANSIENT TRANSFECTION OF D17 CELLS ● TIMING 30 MIN
1. Plate D17 cells in either an ECM-coated glass vessel or a tissue culture–treated
polystyrene multiwell dish to a confluency of 50–80% and leave them to adhere
at room temperature for 30 min to 24 h.
2. After the cells have adhered to the culture vessel surface, replace the medium to
remove cell debris.
3. Make up the Fugene HD transfection mixture and treat cells according to the
manufacturer's protocol at a ratio of 3 μl Fugene HD to 2 μg total DNA (3:2)
diluted in sterile water, although we recommend that users empirically
determine their optimal transfection conditions for each transgene. The
transfection reagent can remain on the plated D17 cells indefinitely.
4. Assess gene expression; this can be carried out within 24 h depending on the
type of promoter used to induce transgene expression.
? TROUBLESHOOTING
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D17-c3 (D17) is a motile Drosophila melanogaster cell line. (a) D17 cells plated to
monolayer confluency and scratched with a 200 μl pipette tip (left) and allowed to migrate
into the wounding area over 16 h (right). Representative migration tracks from two cells are
indicated on the right in blue and green. The full movie can be found in Supplementary
Video 2. (b) Measure of instantaneous or step velocity of individual D17 cells from either a
control or SCAR dsRNA treatment; n = 3, 10 cells tracked for each experiment. Error bars
indicate s.e.m. (c) D17 cells treated with SCAR dsRNA and wounded at 0 h (top) and after
16 h (bottom). Inhibition of Arp2/3-mediated actin nucleation by depletion of its activator
SCAR significantly inhibits D17 cell motility. (d) D17 cells after 7 d of treatment with
either control dsRNA (left) or Rho dsRNA (right). Depletion of Rho results in cytokinesis
defects and multinucleate cells. (e) Immunoblots of S2 or D17 lysates for tubulin (DM1α,
Sigma) or Rho1 (p1D9, Developmental Hybridoma Bank, University of Iowa). Lysates were
taken from cells treated with control dsRNA or Rho1 dsRNA for 7 d, and represent equal
protein load as determined by Bradford assay.
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Dynamic protein localization within a migrating D17 cell. D17 cell expressing the
Drosophila microtubule plus-end protein, Orbit/Mast, tagged with GFP under the
metallothionein promoter (pMT GFP-Orbit) imaged by spinning disc confocal microscopy.
The full movie is available as Supplementary Video 1.
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Immunofluorescence localization of cell-cell junction protein Canoe (Cno) in D17 cells.
D17 cell stained for F-actin (left) using Alexa 488 phalloidin (Molecular Probes) and the
junctional protein Canoe (Cno; middle). Canoe localizes specifically to areas of cell-cell
contact.
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TABLE 1
| Troubleshooting table.
Step Problem Possible reason Solution
8A(ii) D17 cells do not detach after
treatment with cell
dissociation buffer
D17 growth medium may remain after
washing with dissociation buffer or D17
cells are present in high density and are
more resistant to dissociation buffer
Incubate D17 cells for longer periods with cell
dissociation buffer. Use a more powerful
electronic pipette to mechanically remove cells
9 D17 cultures die after a small
number of initial passages
Lack of growth factors in the medium can
lead to a death of D17 cells over the course
of several passages. This can be caused by
an improper inactivation of FBS
Be sure that FBS is heat inactivated at a
temperature of 55 °C (see MATERIALS)
D17 cells never reach 100%
confluency, but instead form
large foci and single cells
adopt a spindly morphology
D17 cells were possibly plated at too low a
density
Consider dissociating and passaging the foci with
vigorous pipetting or dissociation buffer into a
smaller culture flask. Consider replacing half the
culture medium with fresh D17 growth medium to
provide fresh growth factors
14, Box 2 D17 cells stop responding to
dsRNA treatment or transient
transfection; D17 cultures
begin to die after more than 20
passages
Although D17 cells are an immortalized
line, they begin to lose their suscep tibility
to RNAi and reach a terminal growth
sometime after 20 passages
Consider ordering new cells or thawing fresh
aliquots of D17 cells
15, 17 Cells do not adhere and
migrate on ECM-cross- linked
glass surfaces
This could be due to an inefficient cross-
linking process or inefficacious ECM
If you are using a UV cross-linking treatment,
determine the power output of the UV source or
use a plasma treatment system. D17 migration can
be impaired by too-low or too-high concentrations
of ECM. The user should empirically test a range
of ECM concentrations to determine the optimal
concentration per ECM batch (see Experimental
design)
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